Introduction
One of the important clinical decisions that must be made when caring for a person with diabetes is to determine if his or her blood glucose is well controlled. If the patient is uncontrolled, treatment intensification or behaviour change counselling is required. Many of the complications of diabetes can be mitigated or avoided by ensuring good glycaemic control. 1 Usually, this decision is made by means of a random blood glucose (RBG) test in the public sector. RBG is measured in the health centre by a nurse using a glucometer. The rule of thumb used by many practitioners is that a patient with a RBG of > 10 mmol/l is uncontrolled. However, guidelines recommend the use of glycated haemoglobin (HbA 1c ) to accurately assess control of blood glucose. 2 An HbA 1c of 7% or less is regarded as good control and the goal of treatment. In Cape Town, health workers were recently allowed to order one HbA 1c test per year, per patient. Currently, approximately 40% of patients receive this test, and as it must be sent away to the laboratory, it is often not available at the time that a clinical decision needs to be taken. 3 This study aimed to determine the validity of clinical decisions based on RBG, when compared to the results obtained by HbA 1c , in a district hospital setting.
The study was a retrospective analysis of existing hospital and laboratory data. A sample size of 350 was recommended to achieve 80% power to detect a correlation of at least 0.2, using a two-sided hypothesis test with a significance level of 0.05. Data were obtained from the National Health Laboratory Service on HbA 1c tests requested by Karl Bremer District Hospital in 2010. The patient records for each of the HbA 1c test results were drawn, and the corresponding RBG obtained that was taken in the outpatient department at the same visit.
Microsoft
® Excel ® was used to capture the quantitative data and Pearson's product-moment correlation coefficient to evaluate the correlation between HbA 1c and RBG, with Spearman's rank correlation coefficient as an alternative for non-normally distributed data. A HbA 1c level of ≤ 7% was taken to represent good control and > 7% poor control. The sensitivity, specificity, predictive values and likelihood ratios of different threshold levels of RBG were then analysed. In addition, the study population was also examined by means of a receiver operating characteristic (ROC) curve to determine the value of RBG with the best combination of sensitivity and specificity to predict poor control of diabetes. Statistica ® version 9 was used to evaluate the data with the assistance of the Centre for Statistical Consultation. 
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If decisions are made on this basis, 23% of 70.8% of patients with poor control will be missed. It implies that of 100 patients seen in the outpatient department, 16 who are poorly controlled will be missed and have a RBG that is less than 9.8 mmol/l. On the other hand, 25% of the 29.2% of patients with good control will be inappropriately labelled as poorly controlled. This implies that of 100 patients, seven will fall into this category and will have an RBG of greater than 9.8 mmol/l when seen. Therefore, overall, a decision made on the basis of RBG would inappropriately categorise 23 of every 100 patients seen. Thus, currently, although decision-making using RBG is based on the best possible cut-off value, almost a quarter of patients would be mismanaged using this system.
In conclusion, the study highlights that a single RBG result
should not be relied upon to make a valid decision about the control of diabetes. It is possible that the mean of a series of RBG results taken over time could have better validity. However, this is not current practice and would require a separate study.
In view of the problems with the number of patients being tested, and doctors having access to the HbA 1c result at the time that the clinical decision is taken, we recommend that point-of-care testing for HbA 1c should be explored. 4 Number of cases = 349
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